Consent Timing and Experience: Modifiable Factors That May Influence Interest in Clinical Research
- 1 March 2012
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 8 (2), 91-96
- https://doi.org/10.1200/jop.2011.000335
Abstract
Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research.Keywords
This publication has 30 references indexed in Scilit:
- The Impact of Consenter Characteristics and Experience on Patient Interest in Clinical ResearchThe Oncologist, 2009
- Influence of Clinical Communication on Patients' Decision Making on Participation in Clinical TrialsJournal of Clinical Oncology, 2008
- Overcoming barriers to cancer clinical trial accrualCancer, 2007
- Provider roles in the recruitment of underrepresented populations to cancer clinical trialsCancer, 2007
- Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programmeBMJ, 2005
- Interventions to Improve Research Participants' Understanding in Informed Consent for ResearchJAMA, 2004
- How to Optimize Physicians’ Communication Skills in Cancer Care: Results of a Randomized Study Assessing the Usefulness of Posttraining Consolidation WorkshopsJournal of Clinical Oncology, 2003
- Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trialThe Lancet, 2002
- African Americans’ views on research and the Tuskegee Syphilis studySocial Science & Medicine, 2000
- Viability of Cancer Clinical Research: Patient Accrual, Coverage, and Reimbursement: American Medical Association Council on scientific AffairsJNCI Journal of the National Cancer Institute, 1991